Meridian Bioscience (VIVO) Akcija Цена

Meridian Bioscience Цена

NASDAQ·ZATVORENO
2,39
​
Tržište je zatvoreno

U poslednjih 19 godina prihod Meridian Bioscience rastao je 8,9 % godišnje i dostigao 333,02 М USD. Zarada po akciji rasla je 8,4 % godišnje u poslednjih 19 godina. Za Meridian Bioscience neto marža od 12,7 % je porasla u odnosu na 11,1 % pre nekoliko godina. Po današnjoj ceni dividendni prinos iznosi otprilike 5,23 %. Odnos isplate je oko 22 % dobiti.

Cena akcije Meridian Bioscience

Pristupite ovim podacima preko Eulerpool API-ja

Meridian Bioscience poslovni model i analiza akcije

Meridian Bioscience Inc. je globalna kompanija specijalizovana za razvoj, proizvodnju i distribuciju test kitova za dijagnozu infektivnih bolesti i drugih medicinskih stanja. Kompanija je osnovana 1976. godine od strane Vilijama Dž. Mota i u početku se fokusirala na razvoj enzimske imunoadsorpcione analize (EIA). Tokom godina, kompanija je rasla i diversifikovala svoje ponude proizvoda, postajući vodeći pružalac dijagnostičkih test kitova za akutna i hronična medicinska stanja, infektivne bolesti, gastrointestinalne infekcije i virologiju. Uspeh kompanije pripisuje se njenom raznolikom asortimanu test kitova u različitim medicinskim oblastima, uključujući imunologiju, infektivne bolesti, polno prenosive bolesti, gastroenterologiju i virologiju. Pored toga, Meridian Bioscience Inc. prati najnovija tehnološka dostignuća u biotehnologiji kako bi osigurala brzo i efikasno funkcionisanje svojih testova. Kompanija posluje globalno, sarađujući sa univerzitetima, istraživačkim institutima, vladinim agencijama i distributerima kako bi osigurala svetsku distribuciju i marketing svojih proizvoda. Ukratko, Meridian Bioscience Inc. je inovativna kompanija specijalizovana za razvoj, proizvodnju i distribuciju test kitova za dijagnozu infektivnih bolesti i drugih medicinskih stanja. Njen širok spektar proizvoda, uključujući proizvode za imunologiju, dijagnostiku infektivnih bolesti, test kitove za polno prenosive bolesti, gastroenterologiju, virologiju i molekularnu dijagnostiku, uz napredne tehnologije, pruža brzu, tačnu i pouzdanu dijagnostičku podršku.

Često postavljana pitanja o akciji Meridian Bioscience

The business model of Meridian Bioscience Inc revolves around manufacturing and distributing diagnostic products for the healthcare industry. With a focus on infectious disease testing, the company provides a range of products including molecular and immunoassay tests, as well as reagents and related equipment. Meridian Bioscience Inc aims to develop innovative solutions for quick and accurate diagnosis, helping healthcare professionals worldwide make informed decisions. Through its expertise and continual investment in research and development, the company strives to improve patient outcomes and contribute to the overall public health. Meridian Bioscience Inc's commitment to quality and customer satisfaction is evident in their comprehensive portfolio of diagnostic solutions.

Meridian Bioscience Inc is primarily active in the healthcare and life sciences industries.

The main competitors of Meridian Bioscience Inc in the market are companies like Thermo Fisher Scientific, BD (Becton, Dickinson and Company), Quidel Corporation, and Bio-Rad Laboratories. These companies operate in the healthcare and diagnostics industry, offering similar products and services. Meridian Bioscience Inc competes based on factors such as product quality, technological advancements, pricing strategy, and customer satisfaction. While Thermo Fisher Scientific is a well-established player in the market, Meridian Bioscience Inc continues to carve its niche through innovative solutions and a strong customer-centric approach.

Meridian Bioscience Inc is a leading life science company that develops and markets a broad range of innovative diagnostic products. Founded in 1976, the company has a rich history and a strong background in developing and commercializing diagnostic tests for various infectious diseases. Meridian Bioscience Inc has evolved over the years and has expanded its product portfolio to cater to the needs of laboratories, hospitals, and other healthcare providers worldwide. With a focus on quality, accuracy, and reliability, the company has garnered a reputation for delivering efficient and effective diagnostic solutions. Meridian Bioscience Inc remains committed to advancing healthcare and improving patient outcomes through its cutting-edge diagnostic technologies and dedication to innovation.

Meridian Bioscience Inc has achieved several significant milestones throughout its history. One notable accomplishment is the company's development and commercialization of innovative diagnostic test kits for various diseases and healthcare conditions. Furthermore, Meridian Bioscience Inc has consistently expanded its product portfolio, introducing novel technologies to improve healthcare outcomes. The company's dedication to research and development has led to the successful launch of multiple FDA-cleared and CE-marked diagnostic tests. Meridian Bioscience Inc's commitment to quality has enabled it to establish a strong presence in the global diagnostics market.

Meridian Bioscience Inc is primarily present in the United States.

Meridian Bioscience Inc represents a strong set of values and corporate philosophy. The company is committed to quality and innovation in the field of biotechnology. They strive to provide accurate and reliable diagnostic solutions to improve patient care. Meridian Bioscience Inc also prioritizes integrity and ethical conduct in all aspects of their business operations. With a focus on customer satisfaction, they aim to exceed expectations and deliver exceptional products and services. As an industry leader, Meridian Bioscience Inc continues to drive advancements in the healthcare sector through their dedication to excellence and integrity.

7 analitičara trenutno ocenjuje akciju Meridian Bioscience: 6 preporučuje kupovinu, 1 držanje i 0 prodaju.

Po trenutnom kursu akcija Meridian Bioscience kotira 2,14 EUR (2,39 USD).

Akcija Meridian Bioscience (VIVO) kotira na 4 berze, uključujući: NASDAQ (VIVO), London (0K0K.L), Frankfurt (MR4.F), München (MR4.MU).

Meridian Bioscience Inc is a global company specializing in the development, manufacture, and distribution of diagnostic and testing systems for the rapid and accurate identification of infectious diseases. The company was founded in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates several business segments, including diagnostics, OEM, and life science. In the diagnostics segment, the company offers a variety of products for the identification of infectious diseases, including tests for respiratory infections, gastroenteritis, STDs, and Zika virus. Meridian Bioscience's diagnostic products are used in clinical laboratories, hospitals, medical practices, and research laboratories worldwide. The OEM segment of Meridian Bioscience offers customized diagnostic products tailored to the specific requirements of OEM customers. This includes both raw materials and finished products that can be integrated into customers' diagnostic products. The OEM segment of Meridian Bioscience works closely with OEM customers to provide customized, cost-effective, and high-quality products. In the life science segment, Meridian Bioscience offers a wide range of products, including enzymes, antibodies, proteins, buffering solutions, and labeling reagents. These products are used in research and development, diagnostics, and industry. Meridian Bioscience has experienced strong growth in recent years, driven by the introduction of new products, expansion into new markets, and the acquisition of other companies. An example of this is the acquisition of the Bioline Group in 2018, a leading provider of molecular biology products used in research and diagnostics. Meridian Bioscience is committed to developing and manufacturing high-quality products that deliver fast and accurate results. The company works closely with customers and partners to develop innovative products that meet the needs of the healthcare industry. With its wide range of products and commitment to innovation and quality, Meridian Bioscience will continue to play an important role in the diagnostics industry.

Prihod se trenutno ne može izračunati za Meridian Bioscience.

Dobit se trenutno ne može izračunati za Meridian Bioscience.

KGV se trenutno ne može izračunati za Meridian Bioscience.

KUV se trenutno ne može izračunati za Meridian Bioscience.

Eulpool score kvaliteta za Meridian Bioscience je 6/10.

ISIN za Meridian Bioscience je US5895841014. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.

WKN za Meridian Bioscience je 871583. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.

Ticker za Meridian Bioscience je VIVO. Simbol tikera se koristi za trgovinu akcijama Meridian Bioscience na berzanskom tržištu.

Фер вредностTerminal
2,15 USD
Над-/ПодцењеностTerminal
Адекватно вредна
Сектор
Индустрија
Медицинска опрема и понуде
Број акција
Запослени
Приход по запосленом
504.572,73 USD
Раст прихода Ø5 година
Раст EBIT Ø5 година
Раст нето добити Ø5 година
Веб сајт meridianbioscience.com
Валута
USD
Јавна понуда
29. јул 1986.
ISIN
US5895841014
CUSIP
589584101
SEDOL
2580265
Тржишна капитализација
106,06 М USDMicro Cap
Опсег од 52 недеље
AAQS
7 / 10
PEG
—
P/E однос
P/Ee 2023
2,84
P/Ee 2024
4,05
P/Ee 2025
5,65
P/S
P/Se
0,36
EV/EBIT
—
P/B однос
0,29
ROE (Поврат на капитал)
ROA (Поврат на имовину)
ROCE (Поврат на ангажовани капитал)
ROIC (Поврат на уложени капитал)
10,80 %
Zadnje ažurirano 14. окт 2026. 17:32

Meridian Bioscience Тикер

FRANKFURT · MR4.FLONDON · 0K0K.LMINHEN · MR4.MUNASDAQ · VIVO

Meridian Bioscience FIGI

MR4:GF · BBG000GT3TJ1MR4:GS · BBG000GT4YY2VIVOUSD:XB · BBG00JSL7CZ9VIVOUSD:XS · BBG00JSL7DF9VIVOGBX:B1 · BBG00L2YZQT9